|
SkyePharma launches asthma treatment in Germany
Stock Market Wire flutiform® was approved for the treatment of asthma maintenance therapy in Germany by its regulatory authority, Bundesinstitut für Arzneimittel und Medizinprodukte (BfARM), in July. Following the launch offlutiform® in Germany, a milestone of €4.0m is … SkyePharma Launches Flutiform In Germany – Quick Facts |
View full post on asthma – Google News